Best Healthcare Companies in Denmark
The 344 best Healthcare companies in Denmark in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Falck.
Denmark's Healthcare sector, ranked here by disclosed equity funding across 344 tracked companies, tells a story where one name dominates the math. Falck has pulled in $1.6B, which accounts for the overwhelming bulk of the $2.1B total funding pool. That's not a rounding error. Godt Smil sits second at $104M, then Freya at $38M, and the numbers drop fast from there. So if you're trying to read scale in this directory, the gap between Falck and everyone else is the first thing to internalize.
The global backdrop gives that concentration some context. Healthcare revenues hit roughly $2 trillion in 2020 and are forecast to reach $2.6T by 2025, compounding at 6.3% annually, driven by consumer demand for affordable, tech-enabled care delivery. Denmark's 344 companies are operating inside that tailwind, and I'd note the digital signal is real: healthcare app installs across hospital, distributor, and life sciences categories are growing at a median 16% year-over-year. Hot R&D focus right now clusters around vaccine candidates and immunogenicity trials. Strict product safety compliance shapes what actually reaches market, which partly explains why funded scale here concentrates in proven operators rather than early-stage bets.
- Global Healthcare to Soar Above $2 Trillion in 2020 with Consumerism a
- Healthcare Consumers in Asia-Pacific Prefer a Single Touchpoint
Ranked: Best Healthcare companies in Denmark
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Falck Provider of emergency road ambulance services | $1.6B | 86 mo ago | 175 | Jakob Riis President and CEO | Optimizely Content ManagementApple iCloud MailMicrosoft 365+16 | — | — | 1 partnership · 1 expansion |
| 2 | Ferrosan Medical Devices Manufacturer of surgical haemostatic products and medical devices | $125M | 107 mo ago | 584 584 → 414 (-29%) · sector median -3% | Rasmus le Fevre CEO | WordPressMySQLPHP+17 | — | 235 patents Hemostatic medical devices and sprayable wound‑sealant compositions for surgical bleeding control | 6 job openings · 1 internship |
| 3 | Godt Smil Chain of dental clinics | $104M | 48 mo ago | 1 | Burkhardt Gieloff Co-Founder | WordPress Block EditorWordPressSentry+24 | — | — | — |
| 4 | Saniona Developer of drugs for CNS/Pain, autoimmune and metabolic diseases | $69M | 70 mo ago | 24 24 → 50 (+108%) · sector median -3% | — | WordPressApple iCloud MailMicrosoft 365+17 | — | 184 patents Kv7 potassium channel modulators and inhibitors for neurological therapeutic applications | — |
| 5 | Abacus Medicine Consulting services for market access, health economics and outcomes research | $58M | 71 mo ago | 1,052 1,052 → 1,072 (+2%) · sector median -3% | John Wagner Co-Founder | WordPressApple iCloud MailMicrosoft 365+14 | — | — | — |
| 6 | Freya CRO focused on clinical development services reproductive health | $38M | 18 mo ago | 7 | Johan Van Hylckama Vlieg CSO and co-founder | — | — | — | 2 awards |
| 7 | Medotech R&D company focused on manufacturing tooth grinding devices for multiple therapeutic areas | $30M | 204 mo ago | — | — | — | — | 21 patents Dental/ oral muscle monitoring and electrical stimulation devices for bruxism treatment | — |
| 8 | Teitur Trophics Provider of neurodegenerative therapeutics development services | $30M | 39 mo ago | 2 | Mathias Ollendorff Co-Founder | WordPressMySQLPHP+9 | — | 12 patents Peptide-based therapeutics targeting inner ear and mastoid disorders | 1 job opening · 2 awards |
| 9 | Octarine Producer of cannabinoid and psilocybin derivatives | $13M | 4 mo ago | 7 | Nick Milne Co-Founder and CSO | — | 3 signals Funding | — | 1 job opening |
| 10 | NNIT Provider of digital transformation solutions, including custom application development, Microsoft D365 &… | $13M | 323 mo ago | 3,083 3,083 → 1,630 (-47%) · sector median -3% | — | VimeoTailwind CSSMicrosoft ASP.NET+11 | — | — | — |
| 11 | Enduro CDMO focused on manufacturing of microbial strains | $12M | 16 mo ago | 13 | Peter Rugbjerg Co-Founder & CEO | — | — | — | — |
| 12 | Chr. Olesen Distributor of ingredients to the livestock, food, and pharma industries | $11M | 128 mo ago | 54 | Mads Christian Olesen CEO | WordPress Block EditorwpBakeryWordPress+24 | — | — | 2 job openings |
| 13 | Scantox Laboratory focused on providing pharmacology, toxicology, and histopathology services | $6M | 52 mo ago | 128 128 → 185 (+45%) · sector median -3% | Jeanet Løgsted Chief Executive Officer | WordPress Block EditorElementorWordPress+30 | — | — | — |
| 14 | Chromaviso Provider of evidence-based lighting solutions for the healthcare sector | $6M | 55 mo ago | 29 | Anders Kryger Co-Founder & CEO | — | — | 16 patents Circadian lighting systems with programmable control and integrated graphical user interface displays. | 1 partnership |
| 15 | Notify Therapeutics Company focused on developing a novel hormone-free fertility treatment for women | $5M | 32 mo ago | 3 | Karin Hartmann Founder & CEO | — | — | — | — |
| 16 | Hemi Standalone headache clinic | $5M | 3 mo ago | — | Benedicte Dahl CEO | Webflow EcommerceWebflowSentry+22 | — | — | 1 expansion |
| 17 | Mirrx Therapeutics Developer of microRNA-blocking oligonucleotides for cancer, cardiovascular, immunological and viral diseases | $4M | 129 mo ago | 11 | Hans Thorleif Møller Founder & CEO | — | — | 33 patents Antisense oligonucleotide design and delivery for cancer and RNA‑targeted therapies | — |
| 18 | InsuSense CRO focused on drug discovery and development for diabetes and other metabolic diseases | $2M | 127 mo ago | 1 | — | — | — | — | — |
| 19 | VenomAid Provider of point-of-care device for determination of snakebite | $2M | 28 mo ago | 11 | Cecilie Knudsen Co-Founder | — | — | — | — |
| 20 | Medicus Engineering Developer of devices for neuropathy, pressure soar and glucose level monitoring | $910K | 79 mo ago | 1 | Jesper Fleischer Co-Founder | — | — | 9 patents Physiological monitoring devices and closed-loop insulin infusion control systems | — |
| 21 | AdaptVac Developer of therapeutic and prophylactic vaccines | $888K | 74 mo ago | 6 | — | — | — | — | — |
| 22 | Biomonitor Provides CRO , patient monitoring and other biopharma development services | $877K | 158 mo ago | 1 | Arsalan Kharazmi Co-Founder & CEO | — | — | 7 patents Immunogenicity testing and patient suitability prediction for biopharmaceutical therapies | — |
| 23 | OSAA Manufacturer of medical devices | $838K | 65 mo ago | 2 | Jes Broeng Co-Founder | — | — | — | 2 expansions |
| 24 | Omiics Provider of RNA sequencing, laboratory, bioinformatics, and consulting services | $577K | 64 mo ago | 7 | Susanne Veno Co-Founder & CEO | — | — | — | — |
| 25 | Blue Cell Therapeutics Developer of stem cell therapies for the treatment of multiple diseases | $453K | 60 mo ago | 16 16 → 15 (-6%) · sector median -3% | Soren Sheikh CEO | — | — | — | — |
| 26 | Technicon Provider of unspecified technical services | $380K | 84 mo ago | 101 | — | StatamicApple iCloud MailPHP+9 | — | — | 2 job openings · 1 launch |
| 27 | Albumedix Offering albumin-based products and technologies that facilitate the development of biotherapeutics | $316K | 69 mo ago | 106 | — | — | — | 66 patents Engineered albumin proteins and conjugates for targeted drug delivery and therapeutic applications. | — |
| 28 | Danish Lifescience Cluster Network fostering collaboration in life science and welfare technology | $235K | 34 mo ago | 67 | — | WordPressMySQLPHP+14 | — | — | 2 partnerships |
| 29 | Biogenity Contract research organization specializing in omics research and discovery | $203K | 77 mo ago | — | Louis Loeb Co-Founder & Cco | BootstrapApache HTTP ServerCloudflare+9 | — | — | 3 job openings |
| 30 | BioRepeller Bio-resistant polymer coating for Medical Devices | $180K | 156 mo ago | — | Kristian Kolind Co-Founder | — | — | — | — |
| 31 | New Nordic Manufacturer of drugs for diabetes, obesity, hemophilia, and hormone therapy | $145K | 51 mo ago | 64,319 64,319 → 62,524 (-3%) · sector median -3% | John Dawber Corporate Vice President & Managing Director | Adobe Experience ManagerApple iCloud MailJava+18 | 174 signals Leadership · M&A · Earnings | 3 patents Cooling solutions for computer rack halls and data center equipment | — |
| 32 | Joninn Provider of medical device design & development and consulting services | $116K | 92 mo ago | — | Jacques Jonsman Founder | WordPressMySQLPHP+14 | — | — | — |
| 33 | BioPorto Diagnostics In vitro diagnostic tests and consumables | — | 13 mo ago | 39 39 → 44 (+13%) · sector median -3% | Peter Mørch Eriksen Group Chief Executive Officer | WordPressMySQLPHP+24 | 6 signals ▼65% Earnings · Capital raise · Leadership | 13 patents Clinical diagnostic assays targeting specific biomarker isoforms, notably renal injury markers | — |
| 34 | Zealand Pharma Developer of protein therapies for the treatment of diabetes and gastrointestinal diseases | — | 29 mo ago | 235 | Adam Steensberg CEO | Apple iCloud MailMicrosoft 365GSAP+15 | 11 signals ▼27% Announcements · Capital raise · Earnings | 1,274 patents Peptide therapeutics targeting IL‑23 receptor and gut‑hormone analogues (GLP‑2, glucagon) | 1 award |
| 35 | Ambu Company specializes in developing, producing, and marketing single-use medical devices | — | 38 mo ago | 4,917 4,917 → 2,486 (-49%) · sector median -3% | Britt Jensen Co-CEO | Cart FunctionalityDynamicwebApple iCloud Mail+14 | 4 signals ▲300% Leadership | 971 patents Single-use airway and endoscopic devices with integrated imaging and noise-reduction technology | — |
Top 12 Healthcare companies in Denmark
#1
Series A · Copenhagen, Capital Region of Denmark · founded 2018 · 7 employees$12.8Mraised▾
Producer of cannabinoid and psilocybin derivatives
- Jan 2026Series A$5.9M
- Nov 2023Series A$4.6M
- Sep 2022Seed$2M
- Mar 2021Seed$2.2M
#2
Seed · Frederiksberg, Capital Region of Denmark · founded 2023$4.7Mraised▾
It is a wellness company that offers services and resources to support individuals on their journey to wellness. They provide information, forms, and rates for their offerings, and can be contacted via email or phone.
- Feb 2026Seed$4.7M
#3
Series A · Copenhagen, Capital Region of Denmark · founded 2023 · 7 employees$38Mraised▾
CRO focused on clinical development services reproductive health
- Nov 2024Series A$11.8M
- Dec 2023Series A$38M
#4
Series A · Copenhagen, Capital Region of Denmark · founded 2019 · 13 employees$12.4Mraised▾
CDMO focused on manufacturing of microbial strains
- Feb 2025Series A$12.4M
- Apr 2022Seed—
#5
Late Stage · Copenhagen, Capital Region of Denmark · founded 1906 · 175 employees$1.6Braised▾
Provider of emergency road ambulance services
#6
Series A · Horsens, Central Denmark Region · founded 2008 · 1 employees$104.1Mraised▾
Operator of a chain of dental clinics intended to offer implants and advanced dental treatments. The company's clinic specializes in teeth implants, dentures, porcelain crowns, root canal treatment, teeth whitening and other related dental services, enabling its patients to get quality dental services at an affordable rate.
#7
Series A · Aarhus, Capital Region of Denmark · founded 2020 · 2 employees$30Mraised▾
Provider of neurodegenerative therapeutics development services
- Mar 2023Series A$30M
- 2020Seed—
#8
Public · Ballerup, Capital Region of Denmark · founded 2011 · 24 employees$69Mraised▾
Saniona is focused on developing drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases, and treatment of pain. Its drug pipeline includes Tesofensine, a triple monoamine reuptake inhibitor for Obesity (Phase 2); Tesomet, a combination of tesofensine and metoprolol for Type 2 diabetes (Phase 2) and Prader-Willi syndrome (Phase 1); NS2359, a triple monoamine reuptake inhibitor for cocaine addiction (Phase 2); AN363 (GABAA α2/α3 program) for neuropathic pain (Preclinical). The company also has developed drugs for Ataxia, Parkinson's, and IBD disease.
- Aug 2020Post IPO$65M
- May 2017Post IPO$4M
#9
Acquired · Soborg, Capital Region of Denmark · founded 1920 · 584 employees$125.3Mraised▾
Manufacturer of surgical haemostatic products and medical devices. It develops and manufactures products for haemostasis and biopsy procedures. These include absorbable gelatin sponges, haemostatic matrices, and a handheld breast biopsy device. The company provides a full range of services from initial product conception and development through to manufacturing. Products are CE marked and FDA approved, adhering to GMP regulations.
#10
Series A · Copenhagen, Capital Region of Denmark · founded 2021 · 3 employees$5.3Mraised▾
It is a biotech company focused on developing a novel hormone-free fertility treatment for women with diminished ovarian reserve. They target the initial ovarian follicle development in the hormone-independent phase to address infertility. The company has received funding from Lundbeckfonden BioCapital and +ND Capital.
- Sep 2023Series A$5.3M
#11
Series A · Copenhagen, Capital Region of Denmark · founded 2004 · 1052 employees$57.6Mraised▾
Abacus Medicine offers consulting services for market access, health economics, and outcomes research. They provide services for strategic business development and support, quality and compliance, cGMP, clinical monitoring, health economic evaluations, and pharmaceutical sales.
#12
Seed · Virum, Capital Region of Denmark · founded 2017 · 11 employees$1.8Mraised▾
VenomAid provides diagnostic solution to the snakebite crisis. The product is a point-of-care device that provides a diagnostic result within minutes along with identifying the type of snake. The device works when loading blood is transferred directly from the site of the bite onto the device.
- Jan 2024Seed$1.8M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.